Bhubaneswar: AIIMS Bhubaneswar is set to be accorded the status of Centre of Excellence (CoE) for management and research of ...

The Union Government is committed to eradicating Sickle Cell Anaemia by the year 2047, Union Minister of Tribal Affairs, Jual ...

Graves' disease and thyroid eye disease (TED) - TSH antagonist Autosomal polycystic kidney disease (ADPKD) - SST3 agonist A live question-and-answer session will follow the formal presentations. To ...

Crinetics Pharmaceuticals trades at a steep discount while maintaining strong analyst support and a ~$3B valuation. Learn why ...

High testosterone in women can stem from conditions like PCOS and insulin resistance. Symptoms may include acne, excess hair ...

(MENAFN- GetNews) The Key Congenital Adrenal Hyperplasia Companies in the market include - Neurocrine Biosciences, Spruce Biosciences, Neurocrine Bioscience, BridgeBio Pharma, Crinetics ...

A federal court has denied the request by former Smith County Jail medical provider Turn Key Health to dismiss claims against them involving the death of an inmate.The family of deceased inmate ...

About Congenital Adrenal Hyperplasia Congenital adrenal hyperplasia (CAH) is a rare genetic condition that results in an enzyme deficiency that alters the production of adrenal steroid hormones ...

Orlando, Florida — New data add to the evidence supporting use of crinecerfont for the treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, in both adults and ...

CRENESSITY is the first and only classic CAH treatment that directly reduces excess adrenocorticotropic hormone and downstream adrenal androgen production, allowing for glucocorticoid dose reduction.

Congenital adrenal hyperplasia companies are Crinetics Pharmaceuticals, Diurnal Limited, Adrenas Therapeutics, Neurocrine Biosciences, Lundbeck, Bridgebio, Spruce ...